Biopharmaceutical Stocks Recent News
ZIOPHARM Announces Clinical Data On Brain Cancer Drug
3 Biotech Catalysts Expected This Week
Here's Why Ophthotech Is Trading Down On Regeneron's News
Why Galectin Therapeutics Just Lost Nearly Half Its Market Cap
Arbor Pharma Announces Acquisition Of Xenoport At A 60% Premium
GeoInvesting Says Anavex Life Sciences' Stock Has A Book Value Of Just $0.36
Chiasma Plunges 60% Following FDA Review, CEO 'Surprised, Disappointed And Respectfully Disagree With The Decision'
Here's Why Navidea Biopharmaceuticals Surged 25%
PTC Therapeutics Spikes 40% After Translarna Update In England
AbbVie Falling After Q4 Report, 2016 Guidance Affirmation
Fate Therapeutics Gives Up Gains After Early Morning Surge
AEterna Zentraris Surged 17%: Here Is What You Need To Know